The tumor suppressor role of miR-155-5p in gastric cancer

被引:38
|
作者
Li, Shiqing [1 ]
Zhang, Tao [1 ]
Zhou, Xiaoqing [1 ]
Du, Zonghan [1 ]
Chen, Fumin [1 ]
Luo, Jun [1 ]
Liu, Qingsong [2 ]
机构
[1] North Sichuan Med Coll, Clin Coll 2, Ctr Hosp Nanchong City, Dept Gastroenterol, Nanchong 637000, Sichuan, Peoples R China
[2] North Sichuan Med Coll, Affiliated Hosp, Clin Lab Dept, 63 Wenhua Rd, Nanchong 637000, Sichuan, Peoples R China
关键词
microRNA-155-5p; proliferation; apoptosis; gastric cancer; INHIBITS HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; PROGNOSIS; PROMOTES; METASTASIS; GROWTH; EXPRESSION; INVASION;
D O I
10.3892/ol.2018.8932
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastric cancer (GC) is the fifth most common type of malignant tumor worldwide and the most common cause of cancer-associated mortality in China. Recent studies revealed that microRNAs (miRNAs) function in the pathogenesis of GC, and that miR-155-5p expression is downregulated in GC tissues. However, the function of miR-155-5p has not been fully identified. In the present study, it was demonstrated that overexpression of miR-155-5p inhibited GC-cell proliferation and promoted apoptosis, while downregulation of miR-155-5p promoted GC-cell proliferation and decreased the cisplatin sensitivity of GC cells. Mitogen-activated protein kinase kinase kinase 10 was demonstrated to be a potential target gene of miR-155-5p. In conclusion, an antitumor role of miR-155-5p in gastric cancer was suggested.
引用
收藏
页码:2709 / 2714
页数:6
相关论文
共 50 条
  • [31] MiR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1
    Li, Ning
    Cui, Tao
    Guo, Wenling
    Wang, Dianwei
    Mao, Li
    ONCOTARGETS AND THERAPY, 2019, 12 : 3181 - 3196
  • [32] MiR-424 plays a tumor suppressor role in cervical cancer via regulating ERK/MAPK signaling pathways
    Yu, Bin
    Juan, Juan
    Byanjanker, Sunita
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (06): : 7173 - 7181
  • [33] MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9
    Liu, Qi
    Jiang, Jianwu
    Fu, Yang
    Liu, Tao
    Yu, Yang
    Zhang, Xiefu
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 105 : 420 - 427
  • [34] Circular RNA circ_SETD2 represses breast cancer progression via modulating the miR-155-5p/SCUBE2 axis
    Shen, Yuanyuan
    Zhang, Mengmeng
    Da, Liangshan
    Huang, Wei
    Zhang, Congjun
    OPEN MEDICINE, 2020, 15 (01): : 940 - 953
  • [35] Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV
    Duan, Yantao
    Hu, Lei
    Liu, Bing
    Yu, Beiqin
    Li, Jianfang
    Yan, Min
    Yu, Yingyan
    Li, Chen
    Su, Liping
    Zhu, Zhenggang
    Xiang, Ming
    Liu, Bingya
    Yang, Qiumeng
    MOLECULAR CANCER, 2014, 13
  • [36] Tumor Suppressor PTPRJ Is a Target of miR-155 in Colorectal Cancer
    Zhang, Xiao-Fei
    Tu, Rongfu
    Li, Keke
    Ye, Pengxiang
    Cui, Xiaofeng
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (10) : 3391 - 3400
  • [37] HOXA5 is a tumor suppressor gene that is decreased in gastric cancer
    Peng, Xudong
    Zha, Lang
    Chen, Anqi
    Wang, Ziwei
    ONCOLOGY REPORTS, 2018, 40 (03) : 1317 - 1329
  • [38] Implication of miR-155-5p and miR-143-3p in the Vascular Insulin Resistance and Instability of Human and Experimental Atherosclerotic Plaque
    Gonzalez-Lopez, Paula
    Ares-Carral, Carla
    Lopez-Pastor, Andrea R.
    Infante-Menendez, Jorge
    Gonzalez Illaness, Tamara
    Vega de Ceniga, Melina
    Esparza, Leticia
    Beneit, Nuria
    Luis Martin-Ventura, Jose
    Escribano, Oscar
    Gomez-Hernandez, Almudena
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
  • [39] miR-505 acts as a tumor suppressor in gastric cancer progression through targeting HMGB1
    Tian, Liang
    Wang, Zheng-Yu
    Hao, Jun
    Zhang, Xiao-Yu
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (05) : 8044 - 8052
  • [40] A review on the role of MiR-193a-5p in oncogenesis and tumor progression
    Tang, Weixiang
    Rao, Yuhua
    Pi, Longsheng
    Li, Jinping
    FRONTIERS IN ONCOLOGY, 2025, 15